Terms: = Head and neck cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Prognosis
16 results:
1. TOMM34 promotes cell proliferation, migration, and invasion of OSCC and modulates mitochondrial function.
Huang Y; Chen Z; Chen X; Chen X; Xu M
J Oral Pathol Med; 2023 Jan; 52(1):47-55. PubMed ID: 36367442
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a BRAF/PA28γ/mek1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.
Xie C; Li Z; Hua Y; Sun S; Zhong L; Chen Q; Feng H; Ji N; Li T; Zhou X; Zeng X; Tang Z; Sun C; Li J; Chen Q
Cell Death Dis; 2022 Aug; 13(8):701. PubMed ID: 35961969
[TBL] [Abstract] [Full Text] [Related]
3. Integrative pan-cancer analysis of mek1 aberrations and the potential clinical implications.
Zhou Z; Peng B; Li J; Gao K; Cai Y; Xu Z; Yan Y
Sci Rep; 2021 Sep; 11(1):18366. PubMed ID: 34526571
[TBL] [Abstract] [Full Text] [Related]
4. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract] [Full Text] [Related]
5. CD147 promotes invasion and MMP-9 expression through MEK signaling and predicts poor prognosis in hypopharyngeal squamous cell carcinoma.
Suzuki S; Toyoma S; Kawasaki Y; Nanjo H; Yamada T
Adv Clin Exp Med; 2021 Jan; 30(1):41-48. PubMed ID: 33529506
[TBL] [Abstract] [Full Text] [Related]
6. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract] [Full Text] [Related]
7. p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier.
Yuan L; Mo SW; Xu ZY; Lv H; Xu JL; Guo KB; Hu C; Wang XF; Chen GP; Qin JJ; Cheng XD
Pharmacol Res; 2021 Mar; 165():105411. PubMed ID: 33401002
[TBL] [Abstract] [Full Text] [Related]
8. Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma.
Toxopeus E; Lynam-Lennon N; Biermann K; Dickens G; de Ruiter PE; van Lanschot J; Reynolds JV; Wijnhoven B; O'Sullivan J; van der Laan L
Exp Biol Med (Maywood); 2019 Oct; 244(14):1210-1219. PubMed ID: 31390899
[TBL] [Abstract] [Full Text] [Related]
9. KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid cancer.
Owen DH; Konda B; Sipos J; Liu T; Webb A; Ringel MD; Timmers CD; Shah MH
J Natl Compr Canc Netw; 2019 May; 17(5):409-413. PubMed ID: 31085763
[TBL] [Abstract] [Full Text] [Related]
10. Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy.
Gomez-Millan J; Pajares B; Perez-Villa L; Carnero A; Alvarez M; De Luque V; Rivas F; Trigo JM; Toledo MD; Alba E; Medina JA
BMC Cancer; 2016 Oct; 16(1):829. PubMed ID: 27793200
[TBL] [Abstract] [Full Text] [Related]
11. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
[TBL] [Abstract] [Full Text] [Related]
12. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ganly I; Ricarte Filho J; Eng S; Ghossein R; Morris LG; Liang Y; Socci N; Kannan K; Mo Q; Fagin JA; Chan TA
J Clin Endocrinol Metab; 2013 May; 98(5):E962-72. PubMed ID: 23543667
[TBL] [Abstract] [Full Text] [Related]
13. Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.
Mountzios G; Kostopoulos I; Kotoula V; Sfakianaki I; Fountzilas E; Markou K; Karasmanis I; Leva S; Angouridakis N; Vlachtsis K; Nikolaou A; Konstantinidis I; Fountzilas G
PLoS One; 2013; 8(1):e54048. PubMed ID: 23365645
[TBL] [Abstract] [Full Text] [Related]
14. The CDKN2A and MAP kinase pathways: molecular roads to primary oral mucosal melanoma.
Hsieh R; Nico MM; Coutinho-Camillo CM; Buim ME; Sangueza M; Lourenço SV
Am J Dermatopathol; 2013 Apr; 35(2):167-75. PubMed ID: 23000904
[TBL] [Abstract] [Full Text] [Related]
15. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.
Tong M; Chan KW; Bao JY; Wong KY; Chen JN; Kwan PS; Tang KH; Fu L; Qin YR; Lok S; Guan XY; Ma S
Cancer Res; 2012 Nov; 72(22):6024-35. PubMed ID: 22991305
[TBL] [Abstract] [Full Text] [Related]
16. MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.
Luangdilok S; Box C; Harrington K; Rhŷs-Evans P; Eccles S
Eur J Cancer; 2011 Mar; 47(4):520-9. PubMed ID: 21074412
[TBL] [Abstract] [Full Text] [Related]
